Advertisement
Letter to the Editor| Volume 38, e21-e22, March 2017

Download started.

Ok

Applicability of the modified CHA2DS2-VASc score for stroke risk stratification in Caucasian atrial fibrillation patients

Published:November 15, 2016DOI:https://doi.org/10.1016/j.ejim.2016.11.006
Applicability of the modified CHA2DS2-VASc score for stroke risk stratification in Caucasian atrial fibrillation patients
Previous ArticleBleeding in patients with atrial fibrillation treated with dabigatran, rivaroxaban or warfarin
Next ArticleStatins for inflammatory bowel disease: Can off-label drug help it?
      Since 2010, guidelines recommend the use of the CHA2DS2-VASc score to estimate stroke risk in non-valvular atrial fibrillation (AF) patients [
      • Kirchof P.
      • Benussi S.
      • Kotecha D.
      • Ahlsson A.
      • Atar D.
      • Casadei B.
      • et al.
      2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS.
      Eur Heart J. 2016; https://doi.org/10.1093/eurheartj/ehw210
      ]. The CHA2DS2-VASc is a simple, clinical risk factor-based approach to thromboprophylaxis, which has been validated in different cohorts and is widely used [
      • Lip G.Y.
      • Nieuwlaat R.
      • Pisters R.
      • Lane D.A.
      • Crijns H.J.
      Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation.
      Chest. 2010; 137: 263-272
      ]. It has shown to help identify individuals with truly low thromboembolic risk (i.e. CHA2DS2-VASc score of 0 for men or 1 for women), who require no anticoagulation, thus simplifying anticoagulation decision-making [
      • Coppens M.
      • Eikelboom J.W.
      • Hart R.G.
      • Yusuf S.
      • Lip G.Y.
      • Dorian P.
      • et al.
      The CHA2DS2-VASc score identifies those patients with atrial fibrillation and a CHADS2 score of 1 who are unlikely to benefit from oral anticoagulant therapy.
      Eur Heart J. 2013; 34: 170-176
      ].

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to European Journal of Internal Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Kirchof P.
        • Benussi S.
        • Kotecha D.
        • Ahlsson A.
        • Atar D.
        • Casadei B.
        • et al.
        2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS.
        Eur Heart J. 2016; https://doi.org/10.1093/eurheartj/ehw210
        View in Article
        • Lip G.Y.
        • Nieuwlaat R.
        • Pisters R.
        • Lane D.A.
        • Crijns H.J.
        Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation.
        Chest. 2010; 137: 263-272
        View in Article
        • Coppens M.
        • Eikelboom J.W.
        • Hart R.G.
        • Yusuf S.
        • Lip G.Y.
        • Dorian P.
        • et al.
        The CHA2DS2-VASc score identifies those patients with atrial fibrillation and a CHADS2 score of 1 who are unlikely to benefit from oral anticoagulant therapy.
        Eur Heart J. 2013; 34: 170-176
        View in Article
        • Siu C.W.
        • Lip G.Y.
        • Lam K.F.
        • Tse H.F.
        Risk of stroke and intracranial hemorrhage in 9727 Chinese with atrial fibrillation in Hong Kong.
        Heart Rhythm. 2014; 11: 1401-1408
        View in Article
        • Chao T.F.
        • Wang K.L.
        • Liu C.J.
        • Lin Y.J.
        • Chang S.L.
        • Lo L.W.
        • et al.
        Age threshold for increased stroke risk among patients with atrial fibrillation: a nationwide cohort study from Taiwan.
        J Am Coll Cardiol. 2015; 66: 1339-1347
        View in Article
        • Chao T.F.
        • Lip G.Y.H.
        • Liu C.J.
        • Tuan T.C.
        • Chen S.J.
        • Wang K.L.
        • et al.
        Validation of a modified CHA2DS2-VASc score for stroke risk stratification in Asian patients with atrial fibrillation. A nationwide cohort study.
        Stroke. 2016; 47: 2462-2469
        View in Article

      Article info

      Publication history

      Published online: November 15, 2016
      Accepted: November 7, 2016
      Received: November 3, 2016

      Footnotes

      ☆Funding: none.

      Identification

      DOI: https://doi.org/10.1016/j.ejim.2016.11.006

      Copyright

      © 2016 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect
      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


      RELX